Member Article

Aesica Pharmaceuticals partner with University of Bradford

Pharmaceutical manufacturer Aesica have announced a new partnership with the University of Bradford, which will see the company take advantage of facilities at the institution’s Centre for Pharmaceutical Engineering Science.

Business development manager, Dr. Riddi Shukla, led the deal and offered Aesica access to advanced technologies at the centre, which rely on the Good Manufacturing Practice (GMP) capabilities of the pharmaceutical company.

Both parties will benefit from contract, as Aesica will use processing technologies such as hot metal extrusion at Bradford’s facility, and the University will gain access to GMP standards.

Aesica plan to manufacture clinical trial supplies at the centre, and the firm emphasised the importance of the alliance between the business and the University.

Paul Titley, managing director of Formulation Development at Aesica, said: “We provide GMP contract manufacturing services to six other universities, but this partnership is particularly important and unique as it is mutually beneficial.

“By working with such organisations at an early stage we would hope to cement long term development and manufacturing partnerships and expedite the leap from concept to commercialisation with a clear and proven route to market.”

Dr. Shukla commented: “We were keen to tap into for the benefit of our contacts within the multinational pharma community. Our facilities at the Centre are second to none and we believe this coupled with our research expertise will deliver significant benefits to Aesica as the partnership evolves.”

This was posted in Bdaily's Members' News section by Miranda Dobson .